Yale University

New Haven, Connecticut
Henry Bronson Professor of Pharmacology, Yale University
Chairman, Consortium for the Globalization of Chinese Medicine

Research

While the therapeutic benefits of Traditional Chinese Medicine (TCM) have been recognized anecdotally for centuries, they have often been discounted as “alternative therapies” because there was little scientific proof of effectiveness. Dr. Cheng’s laboratory is working to bring TCM into the mainstream of Western medicine, with hopes of reducing the side effects of chemotherapy, while enhancing the benefits.

Since the late 1990s, Dr. Cheng’s team has been exploring the therapeutic properties of PHY906, a Chinese herbal medicine formula. They have discovered that cancer treatment with PHY906, combined with chemotherapy, alleviates the unpleasant gastrointestinal side effects of chemotherapy for colon, rectal, pancreatic and liver cancer patients. Moreover, their research demonstrated that PHY906 also has its own, solo anti-tumor attributes. If there is continued success in three ongoing clinical trials, PHY906 could become one of the first FDA-approved oral herbal medicines for anti-cancer treatment. Dr. Cheng and his team are also evaluating other TCM herbal formulas that could be part of a new class of drugs.

Dr. Cheng also discovered deoxynucleoside agents that inhibit cellular DNA and hypoxic cancer cells found in lung cancer.  His research also continues to explore the use of anti-viral drugs in preventing or delaying the onset of viruses such Hepatitis B and C and HIV that can lead to liver and other cancers.

Years of NFCR support to Dr. Cheng’s laboratory efforts have led to promising experimental therapeutic technology now being commercialized through the AIM-HI Translational Research Initiative. To learn more, click here.

Bio

Yung-Chi Cheng, Ph.D., received his B.S. in chemistry from Tunghai University in Taiwan and his Ph.D. in biochemical pharmacology from Brown University. Dr. Cheng then performed his postdoctoral work at Yale University from 1972 to 1974. Upon completing this work, Dr. Cheng joined the faculty of the Roswell Park Memorial Institute in Buffalo, NY and worked there until 1979.

Dr. Cheng was a professor at the University of North Carolina (UNC) at Chapel Hill and became the Director of the Developmental Therapeutics Program at UNC’s Cancer Center. In 1989, he returned to Yale University as the Henry Bronson Professor of Pharmacology and Director of the Developmental Therapeutics Program of the Yale Comprehensive Cancer Center.

Dr. Cheng is a member of the Board of Scientific Counselors of the Division of Cancer Treatment for the National Cancer Institute, the AIDS Research Advisory Committee for the National Institutes of Health, the Board of Directors for the American Association for Cancer Research and a member and Chairman of the Therapeutic Study Section at the National Institutes of Health. He was elected as a Special Advisor to the Committee for the Biotechnology Industry in Taiwan, was Chairman of the Action Committee for Medical Biotechnology in Academia Sinica in Taiwan, was Chairman of the Biopharmaceutical Division of Scientific Counselors for the National Health Research Institute in Taiwan and also provided advice on biomedical science research funding for the government in Hong Kong.

Throughout his career, Dr. Cheng has received many honors and awards, including a Leukemia Society of America Scholar Award, the Rhodes Memorial Award from the American Association for Cancer Research, an Outstanding Investigator Award from the National Cancer Institute, an Outstanding Alumni Awards from Tunghai University and Brown University, an Outstanding Investigator Award in Bio-Medical Science from the Society of Chinese Bioscientists in America, the American Society of Pharmacology and Experimental Therapeutics Award and was the BMRC Distinguished Visitor in Singapore.

He has also received several honorary professorships, including from the Union Medical University and the Chinese Academy of Medical Science in China, from Beijing Medical University, from the Institute of Material Medica at the Chinese Academy of Science and he earned the title of Honorary Visiting Scientist at the Institute for the Advancement of Chinese Medicine in Hong Kong. Additionally, Dr. Cheng was elected as an academician of Academia Sinica in 1994 and, in 1998, became a member of the Connecticut Academy of Sciences and Engineering.

Dr. Cheng has been on the editorial or advisory boards of many scientific journals, including Virus GenesCancer Communications and the Chinese Journal of Pharmacology & Toxicology. He also serves as Chairman of the Consortium for Globalization of Chinese Medicine.

NFCR Fellow Dr. Yung-Chi Cheng

Areas of Focus

Cancer Types

Years of NFCR Funding

1991 – Present

Related Content

New Treatment with Combined Immunotherapies is Effective for Drug Resistant Metastatic Lung Cancer

Innovative Research and New Drug Development Continue to Prolong Survival Time of Lung Cancer Patients

Coping With Cancer—It’s Different for Everyone

Everyone’s journey with cancer is different, also unique to them is the way in which they cope with the disease. Taking two late celebrities, Alex Trebek and Chadwick Boseman as an example, we can see the differences in how individuals deal with a cancer diagnosis. Pancreatic cancer may only rank at number nine and ten in terms of most commonly diagnosed cancers amongst men and women (respectively), but most Americans are well aware of the disease ever since Jeopardy host Alex Trebek was diagnosed last year. The deadly disease has a low five-year-survival rate at only 9%. Most Americans are well aware of the disease ever since the late Jeopardy host Alex Trebek was diagnosed in 2019 and sadly passed away in November 2020. Though undoubtedly a trying year for Trebek, his loved ones, and his fans, the game show host publicly battled his cancer with his return to Jeopardy in September 2020. A year-and-a-half after being diagnosed with stage 4 cancer, Trebek became an inspiration for many affected by pancreatic cancer. Despite the side effects, which include fatigue, Trebek returned to the Jeopardy stage to do what he loved most. His passion for living life had his recently published memoir flying off the shelves. Appropriately titled ‘The Answer Is…: Reflections on My Life’, the memoir explores Trebek’s entire life to date – including his childhood through to his life during the COVID-19 pandemic. Though the memoir is not a story specifically about his cancer journey, Trebek used his fame to bring awareness to pancreatic cancer. In partnership with the World Pancreatic Cancer Coalition, Trebek participated in a worldwide awareness initiative wherein he encouraged the public to know the risk factors and the symptoms of the deadly disease. His fame sparked conversation about pancreatic cancer while showing the patients across the world that cancer does not define a person. While Trebek made great efforts to bring awareness to pancreatic cancer, some celebrities choose not to use their diagnosis to spearhead conversation. Actor Chadwick Boseman battled colon cancer before passing away in mid-2020. Unlike Trebek, he chose to keep his journey private. After his death, however, a wave of colon cancer awareness flooded the world. Both Trebek and Boseman are beloved by their fans; however the differences between their journeys with cancer highlight that, even as a celebrity, a cancer diagnosis is an extremely personal experience. For Trebek, raising awareness and talking about his difficult prognosis helped him cope with the news. Boseman found strength in continuing his life as normal, only discussing his cancer treatment with those closest to him. Trebek and Boseman are perfect and timely examples of how each person copes differently. There is no correct way to deal with a cancer diagnosis – whether a new diagnosis or an ongoing experience. Like many aspects of life, seeing someone else handle a situation differently can cause doubt with one’s own approach. However, as Trebek and Boseman nobly demonstrated, deciding whether to speak about a cancer diagnosis publicly is a personal choice. There is no right or wrong way for any patient to navigate such a decision. Each journey […]